Are the Technicals Adding up for TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)?

Investors are sharpening their focus on shares of TRACON Pharmaceuticals, Inc. (NASDAQ:TCON).  The stock saw a move of -2.46% during the latest trading session. The stock price has recently touched $2.97 which has caused investors to take a second look at company shares. With the stock currently trading under the $10 price level, investors may be wondering if the stock is a bargain at the current price.

Here we’ll take a quick glance at how the stock price is currently trading in relation to some of its simple moving averages. At current levels, TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) shares have been seen trading 5.37% away from the 20-day moving average. The stock has been recently separated from the 50-day moving average by -1.55%. Using a broader approach, shares have been trading -2.29% off of the 200-day moving average. After the latest check-in, company stock is -23.87% off of the 50 day high and 19.00% away from the 50 day low price.

Overall, 2017 has been a good year thus far for small-cap stocks. Investors may be examining their portfolios and trying to decide if they have the proper exposure to small-caps. Deciding on small-cap portfolio weighting may depend prominently on the risk appetite for each individual person. Investors also may need to evaluate their short-term and long-term goals when deciding how best to tackle the equity market. Small-cap stocks have historically outperformed early in economic expansion cycles, and underperformed later in the cycles. With the current economic cycle in year eight, it begs the question as to why small-cap stocks have still been chugging along and outperforming certain averages.

In terms of performance, shares of TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) are -37.76% since the start of 2016. Over the past week, shares are 12.96%. Moving out to look at the previous month performance, the stock is at 5.17%. For the quarter, performance is at -8.96%. During the past six months, TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)’s stock has been 19.61% and -46.96% for the last 12 months.

Investors are constantly attempting to find the next great stock to own. Picking the next winner to bolster the portfolio may involve some hard work and a little bit of stock market magic. Sifting through the wealth of information about public companies can be a daunting task. Many sharp investors will attack the equity markets from many different angles. This may include keeping close tabs on fundamental and technical data. This may also include tracking analyst opinions and following what the big money institutions are buying or selling.

Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.